Detalhe da pesquisa
1.
Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019.
J Infect Dis
; 226(1): 1-5, 2022 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35297493
2.
Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment.
Infect Dis (Lond)
; : 1-6, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38743059
3.
Correlation Between Opioid Drug Prescription and Opioid-Related Mortality in Spain as a Surveillance Tool: Ecological Study.
JMIR Public Health Surveill
; 9: e43776, 2023 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37379061
4.
Outcomes and clinical characteristics of the compassionate use of plitidepsin for immunocompromised adult patients with COVID-19.
Int J Infect Dis
; 135: 12-17, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37481109
5.
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort).
EClinicalMedicine
; 28: 100591, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33078138
6.
[Hemolytic anemia secondary to rifampicin in patient diagnosed of pulmonary tuberculosis reinfection]. / Anemia hemolítica secundaria a rifampicina en paciente diagnosticado de reinfección por tuberculosis pulmonar.
Rev Esp Quimioter
; 26(4): 369-70, 2013 Dec.
Artigo
em Espanhol
| MEDLINE | ID: mdl-24399351